Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn National Municipal Income Fund | VFL | Nov 29, 2024 | 10.90 | +1.11 |
Abrdn Total Dynamic Dividend Fund | AOD | Nov 29, 2024 | 8.80 | +1.15 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Nov 29, 2024 | 12.17 | +0.75 |
Absci | ABSI | Nov 29, 2024 | 3.05 | +3.74 |
ABVC Biopharma | ABVC | Nov 29, 2024 | 0.53 | +3.88 |
Ac Immune SA | ACIU | Nov 29, 2024 | 3.40 | +1.19 |
Acacia Research | ACTG | Nov 29, 2024 | 4.55 | +1.34 |
Academy Sports and Outdoors | ASO | Nov 29, 2024 | 49.25 | +0.82 |
Acadia Healthcare | ACHC | Nov 29, 2024 | 40.63 | -1.57 |
Acadia Pharmaceuticals | ACAD | Nov 29, 2024 | 16.32 | +0.18 |
Acadia Realty Trust | AKR | Nov 29, 2024 | 25.85 | -0.88 |
Accel Entertainment | ACEL | Nov 29, 2024 | 11.56 | -0.34 |
Accelerate Diagnostics | AXDX | Nov 29, 2024 | 1.66 | +3.11 |
Accenture A | ACN | Nov 29, 2024 | 362.37 | +0.06 |
Acco Brands | ACCO | Nov 29, 2024 | 5.82 | +0.17 |
Accolade | ACCD | Nov 29, 2024 | 3.86 | +2.93 |
Accuray | ARAY | Nov 29, 2024 | 2.23 | +5.69 |
Acelyrin | SLRN | Nov 29, 2024 | 4.55 | -0.44 |
Achieve Life Sciences | ACHV | Nov 29, 2024 | 4.41 | -1.78 |
Achilles Therapeutics ADR | ACHL | Nov 29, 2024 | 1.08 | +0.47 |
ACI Worldwide | ACIW | Nov 29, 2024 | 56.82 | +0.28 |
Aclarion | ACON | Nov 29, 2024 | 0.18 | +1.58 |
Aclaris Therapeutics | ACRS | Nov 29, 2024 | 4.07 | +6.54 |
ACM Research A | ACMR | Nov 29, 2024 | 17.19 | -0.46 |
Acme United | ACU | Nov 29, 2024 | 44.51 | +0.36 |
ACNB | ACNB | Nov 29, 2024 | 46.86 | -0.21 |
ACRES Commercial Realty | ACR | Nov 29, 2024 | 17.37 | +0.06 |
ACRES Commercial Realty C Pref | ACR-C | Nov 29, 2024 | 25.15 | +0.20 |
ACRES Commercial Realty D Pref | ACR-D | Nov 29, 2024 | 22.80 | +0.18 |
Acrivon Therapeutics | ACRV | Nov 29, 2024 | 7.58 | +0.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.